Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHowden Joinery Regulatory News (HWDN)

Share Price Information for Howden Joinery (HWDN)

Share Price is delayed by 15 minutes
Get Live Data
779.00    0.00 (0.00%)
Bid:
778.50
Ask:
779.50
Spread: 1.00 (0.128%)
Market Cap: £4.21b
HWDN Live PriceLast checked at - London Stock Exchange

Intraday Howden Joinery Share Chart

Share Buyback Programme

3 Jun 2026 08:00

RNS Number : 7321G
Howden Joinery Group PLC
03 June 2026
Β 

3 June 2026

Β 

HOWDEN JOINERY GROUP PLC

("Howdens" or the "Company")

Β 

Β£100 million share buy-back programme

Β 

Further to the announcement of Howdens' intention to repurchase up to Β£100 million of its shares during 2026 (the "Programme") in its 2025 Full Year Results, the Company announces that it has instructed its joint-broker, Deutsche Bank AG, acting through its London branch ("Deutsche Bank"), to execute the first part of the Programme to repurchase up to Β£50 million of its shares commencing on or after 3 June 2026 and ending no later than 31 December 2026. Under this arrangement, Deutsche Bank, an independent third party, will act as principal and will make decisions under the Programme independently from the Company during any closed periods.

Β 

The Company's shareholders authorised the Company to repurchase up to a maximum of 53,903,751 of its ordinary shares at the Annual General Meeting held on 7 May 2026. The aggregate number of shares acquired by the Company pursuant to the Programme shall not exceed the maximum number of shares which the Company is authorised to purchase pursuant to such general authorities as at the time of purchase. The sole purpose of the Programme is to reduce the Company's share capital. Shares repurchased under the Programme will be cancelled or transferred into treasury. Any shares held in treasury have no voting or dividend rights and are used to meet future obligations arising from Company employee share option programmes.

Β 

The Programme is in line with the Company's stated capital allocation policy, which prioritises our strategy of continuing to invest in depots, manufacturing and logistics capabilities and related strategic investments, while delivering a progressive dividend. Any repurchases of shares under the Programme will be carried out on the London Stock Exchange and in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase shares granted by its shareholders (at the applicable time), the Market Abuse Regulation 596/2014 (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018) and Chapter 9 of the Financial Conduct Authority's UK Listing Rules.

Β 

Β 

Enquiries

Β 

Howdens:

Mark Fearon, Director of IR and Communications:

+44(0)771 187 5070

Forbes McNaughton, Company Secretary:

+44(0)207 535 1162

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCUUUWRNBUNRAR
Date   Source Headline
20th Mar 202511:31 amRNSDirector/PDMR Shareholding
19th Mar 20255:00 pmRNSTransaction in Own Shares
19th Mar 20259:00 amRNSAnnual Report and Accounts and Notice of AGM
18th Mar 20255:14 pmRNSTransaction in Own Shares
17th Mar 20255:21 pmRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20255:44 pmRNSTransaction in Own Shares
13th Mar 20257:00 amRNS£100 million share buy-back programme
5th Mar 20254:44 pmRNSHolding(s) in Company
3rd Mar 20253:30 pmRNSDirector/PDMR Shareholding
3rd Mar 20259:19 amRNSTotal Voting Rights
27th Feb 20257:00 amRNS2024 Full Year Results
25th Feb 202511:04 amRNSHolding(s) in Company
19th Feb 20251:46 pmRNSSIP PDMR Notification
3rd Feb 20252:55 pmRNSHolding(s) in Company
3rd Feb 20259:00 amRNSBlock listing Interim Review
3rd Feb 20259:00 amRNSTotal Voting Rights
21st Jan 202510:52 amRNSSIP PDMR Notification
2nd Jan 20259:00 amRNSTotal Voting Rights
19th Dec 20246:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20249:00 amRNSTotal Voting Rights
25th Nov 20245:16 pmRNSDirector/PDMR Shareholding
19th Nov 20243:24 pmRNSDirector/PDMR Shareholding
12th Nov 202412:53 pmRNSDirector/PDMR Shareholding
11th Nov 20242:00 pmRNSDirectorate Change
7th Nov 20247:00 amRNSTrading Update
4th Nov 20243:21 pmRNSHolding(s) in Company
1st Nov 20249:00 amRNSTotal Voting Rights
16th Oct 202410:33 amRNSDirector/PDMR Shareholding
1st Oct 20249:00 amRNSTotal Voting Rights
25th Sep 20241:18 pmRNSHolding(s) in Company
19th Sep 20245:23 pmRNSDirector/PDMR Shareholding
19th Sep 20243:49 pmRNSHolding(s) in Company
18th Sep 20243:32 pmRNSHolding(s) in Company
17th Sep 20242:35 pmRNSHolding(s) in Company
16th Sep 20244:25 pmRNSDirector/PDMR Shareholding
6th Sep 202410:04 amRNSHolding(s) in Company
4th Sep 20243:44 pmRNSHolding(s) in Company
2nd Sep 20244:28 pmRNSDirector/PDMR Shareholding
2nd Sep 20249:00 amRNSTotal Voting Rights
30th Aug 20243:00 pmRNSTransfer of Treasury Shares - Replacement
30th Aug 20242:37 pmRNSDirector/PDMR Shareholding
30th Aug 20242:13 pmRNSTransfer of Treasury Shares
20th Aug 20249:59 amRNSSIP PDMR Notification
7th Aug 20243:07 pmRNSHolding(s) in Company
1st Aug 20249:00 amRNSTotal Voting Rights
1st Aug 20249:00 amRNSBlock listing Interim Review
31st Jul 20244:17 pmRNSDirector/PDMR Shareholding
25th Jul 20247:00 amRNS2024 Half Year Results
23rd Jul 202412:40 pmRNSSIP PDMR Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.